Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liver disease

References

• Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825–832.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease alcoholic. Hepatology. 2005;41:1313–1321.
   PubMed Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699.
   PubMed Web of Science ®Google Scholar
• Anthony PP, Ishak KG, Nayak NC, et al. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 1978;31:395–414.
   PubMed Web of Science ®Google Scholar
• Nagula S, Jain D, Groszmann RJ, et al. Histological-hemodynamic correlation in cirrhosis – a histological classification of the severity of cirrhosis. J Hepatol. 2006;44:111–117.
   PubMed Web of Science ®Google Scholar
• Sethasine S, Jain D, Groszmann RJ, et al. Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology. 2012;55:1146–1153.
   PubMed Web of Science ®Google Scholar
• Hoad CL, Palaniyappan N, Kaye P, et al. A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histological factors. NMR Biomed. 2015;28:706–714.
   PubMed Web of Science ®Google Scholar
• McCorry RB, Palaniyappan N, Chivinge A, et al. Development and evaluation of a nurse-led transient elastography service for the staging of hepatic fibrosis in patients with suspected chronic liver disease. QJM. 2012;105:749–754.
   PubMed Web of Science ®Google Scholar
• Lichtinghagen R, Pietsch D, Bantel H, et al. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol. 2013;59:236–242.
   PubMed Web of Science ®Google Scholar
• Caballero T, Perez-Milena A, Masseroli M, et al. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol. 2001;34:740–747.
   PubMed Web of Science ®Google Scholar
• Calvaruso V, Burroughs AK, Standish R, et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology. 2009;49:1236–1244.
   PubMed Web of Science ®Google Scholar
• Hui AY, Liew CT, Go MY, et al. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B. Liver Int. 2004;24:611–618.
   PubMed Web of Science ®Google Scholar
• Xu S, Wang Y, Tai DC, et al. qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol. 2014;61:260–269.
   PubMed Web of Science ®Google Scholar
• Isgro G, Calvaruso V, Andreana L, et al. The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis. J Gastroenterol. 2013;48:921–929.
   PubMed Web of Science ®Google Scholar
• Parkes J, Guha IN, Roderick P, et al. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat. 2011;18:23–31.
   PubMed Web of Science ®Google Scholar
• Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004;127:1704–1713.
   PubMed Web of Science ®Google Scholar
• Cobbold JF, Crossey MM, Colman P, et al. Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C. J Viral Hepat. 2010;17:537–545.
   PubMed Web of Science ®Google Scholar
• Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol. 2011;25:291–303.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Gurusamy KS, Ntaoula S, et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol. 2011;54:650–659.
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134:960–974.
   PubMed Web of Science ®Google Scholar
• Gomez-Dominguez E, Mendoza J, Rubio S, et al. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther. 2006;24:513–518.
   PubMed Web of Science ®Google Scholar
• Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408.
   PubMed Web of Science ®Google Scholar
• Yoneda M, Mawatari H, Fujita K, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)invasive alcoholic. Dig Liver Dis. 2008;40:371–378.
   PubMedGoogle Scholar
• Nguyen-Khac E, Chatelain D, Tramier B, et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther. 2008;28:1188–1198.
   PubMed Web of Science ®Google Scholar
• Palaniyappan N, Cox E, Bradley C, et al. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol. 2016. [Epub ahead of print]. doi: 10.1016/j.jhep.2016.07.021.
   PubMedGoogle Scholar